Gastrointestinal Cancer Symposium
This symposium highlights the latest clinical advances in gastrointestinal, hepatobiliary and pancreatic cancers. Attendees will learn about recent clinical trials, novel systemic therapies, advanced endoscopic techniques, high-dose radiation, and ablative therapies for metastatic disease. In addition, they will learn about cutting-edge surgical treatments such as Hepatic Artery Infusion and Heated Intraperitoneal Chemotherapy (HIPEC). Additionally, participants will have the chance to network with leading experts in the field.
This meeting is for oncologists, surgeons, gastroenterologists, radiologists, oncology nurses, advanced practice nurses, physician assistants, clinical oncology pharmacists, clinical research staff, cancer center administrators, cancer center program leaders, patient advocates, and medical students. Attendance is open to everyone. We look forward to seeing you!
JOIN US
THIRD ANNUAL GI CANCER
SYMPOSIUM
Presented by the UK Division of Surgical
Oncology and the UK Markey Cancer Center
SAVE THE DATE
Friday, Sept. 12, 2025 &
Saturday, Sept. 13, 2025
REGISTER
WELCOME RECEPTION
Friday, Sept. 12, 2025
5 – 10 p.m.
The Manchester (hotel)
941 Manchester St.
Lexington, KY 40508
SYMPOSIUM
Saturday, Sept. 13, 2025
6:45 a.m. – 4 p.m.
Manchester Reserve
903 Manchester St.
Lexington, KY 40508
KEYNOTE
GASTRIC CANCER FROM KOREA TO KENTUCKY
Han-Kwang Yang, MD, PhD
President, National Cancer Center &
Professor Emeritus, Seoul National University,
Seoul, South Korea
SCHEDULE
Time |
Session |
Speaker |
| 6:00 a.m. | Registration Opens | |
| 6:00–7:00 a.m. | Continental Breakfast | |
| 7:00–7:05 a.m. | GI Cancers in Kentucky Welcome | Prakash Pandalai, MD |
| 7:05–7:40 a.m. | SESSION 1: Markey Cancer Center | B. Mark Evers, MD |
| 7:45-8:10 a.m. | SESSION 2: Phase 1 Clinical Trials in Gastrointestinal Cancer | Meredith Pelster, MD |
| 8:15–9:05 a.m. | SESSION 3: Pancreatic Neoplasms | |
| • 8:15–8:35 a.m. | • Updates in Management of Pancreatic Cystic Neoplasms: Why, When, and How to Manage this Growing Patient Population | Ajay Maker, MD |
| • 8:40–8:55 a.m. | • A Phase 2 Study of mRNA Vaccine Plus Immunotherapy and Chemotherapy for Operable Pancreatic Cancer | Joseph Kim, MD |
| 9:10–10:15 a.m. | KEYNOTE ADDRESS - SESSION 4: Evolution of Surgical Science; How we have worked together against Gastric Cancer | Han-Kwang Yang, MD, PhD |
| 10:20–11:25 a.m. | SESSION 5: Contemporary Management of Liver Metastases in GI and HPB Malignancy | |
| • 10:20–10:35 a.m. | • The Role for Hepatic Artery Infusion Therapy for Unresectable Cholangiocarcinoma | Michael Cavnar, MD |
| • 10:40–11:00 a.m. | • Hepatic Artery Infusion Therapy: What is the Role for Concurrent Chemotherapy in Patients with Hepatic Artery Infusion Therapy | Paul Helft, MD |
| • 11:05–11:25 a.m. | • Orthotopic Liver Transplant for Colorectal Cancer: The Mayo Clinic Experience | Koji Tomiyama, MD, PhD |
| 11:30–11:45 a.m. | SESSION 6: Ask the Expert Panel: Unresectable Colorectal Liver Metastases | • Koji Tomiyama, MD, PhD • Paul Helft, MD • Michael Cavnar, MD |
| 11:45 a.m.–12:45 p.m. | Lunch Break (Provided) | |
| 12:55–1:15 p.m. | SESSION 7: Early Onset Gastrointestinal Cancer | Mautin Barry-Hundeyin, MD |
| 1:20–1:40 p.m. | SESSION 8: Advanced Endoscopy in Upper GI Cancers: What Do We Do and How Do We Do It | Donald Campbell, MD |
| 1:45–2:10 p.m. | SESSION 9: Updates in Organ Preservation for Rectal Cancer | Jeffrey Farma, MD |
| 2:15–2:40 p.m. | SESSION 10: Stereotactic Body Radiation for Oligometastatic Gastro-intestinal Cancers, Where, Who, How Much? | Brian Czito, MD |
| 2:45–3:10 p.m. | SESSION 11: Practice Changing Clinical Trials in Cholangiocarcinoma, HCC, Colorectal Liver Metastases 2020-2025 | Minsig Choi, MD |
| 3:15-3:35 p.m. | SESSION 12: Y90 Radiation Segmentectomy for Hepatocellular Carcinoma: Evolving Evidence and Role of Systemic Therapy | Driss Raissi, MD, MBA |
| 3:45–4:00 p.m. | SESSION 13: Closing Remarks | Joseph Kim, MD |
